Prostate cancer patients can benefit from 5-alpha-reductase inhibitor treatment: a meta-analysis

Prostate cancer patients can benefit from 5-alpha-reductase inhibitor treatment: a meta-analysis

Background The efficacy and safety of 5α-reductase inhibitors (5ARIs) in treating prostate cancer (PCa) have not been fully determined. We performed a meta-analysis to evaluate the effectiveness and safety of 5ARIs for PCa patients. Methods A comprehensive literature search of online databases was c...

Full description

Bibliographic Details
Main Authors:	Tuo Deng, Xueming Lin, Xiaolu Duan, Zihao He, Zhijian Zhao, Guohua Zeng
Format:	Article
Language:	English
Published:	PeerJ Inc. 2020-06-01
Series:	PeerJ
Subjects:	Prostate cancer 5α-Reductase inhibitors Treatment effect Meta-analysis
Online Access:	https://peerj.com/articles/9282.pdf

Similar Items

EFFECTIVENESS OF 5-ALPHA-REDUCTASE INHIBITORS IN PATIENTS WITH PROSTATIC INTRAEPITHELIAL NEOPLASIA OF PERIPHERAL PROSTATE ZONE
by: M. P. Мelnychuk
Published: (2019-04-01)

5-alpha reductase inhibitors and MRI prostates: actively reducing prostate sizes and ambiguity
by: Ziting Wang, et al.
Published: (2023-04-01)

5α-Reductase inhibitor is less effective in men with small prostate volume and low serum prostatic specific antigen level
by: Victor C. Lin, et al.
Published: (2015-09-01)

The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia
by: Eric H. Kim, et al.
Published: (2018-01-01)

Effect of 5-Alpha Reductase Inhibitors on Magnetic Resonance Imaging and Prostate Cancer Detection
by: Juan Morote, et al.
Published: (2024-02-01)

Symptomatic benign prostatic hyperplasia: the role of 5-alpha-reductase inhibitors in the prevention of acute urinary retention and surgical therapy
by: Norma Marigliano, et al.
Published: (2012-01-01)

Evaluation of Sex Hormone Levels in Benign Prostatic Hyperplasia Patients Treated with 5 Alpha-Reductase Inhibitor (Finasteride) in Amara city/Iraq
by: Hashim et al.
Published: (2020-03-01)

Sinomenine Hydrochloride Can Ameliorate Benign Prostatic Hyperplasia by Lowering the 5α-Reductase 2 Level and Regulating the Balance between the Proliferation and Apoptosis of Cells
by: Mao-Si Fan, et al.
Published: (2023-01-01)

Was DHT production by 5α-reductase friend or for in prostate cancer?
by: Takeo eKosaka, et al.
Published: (2014-09-01)

Upregulation of mir-1199-5p is associated with reduced type 2 5-α reductase expression in benign prostatic hyperplasia
by: Zhanliang Liu, et al.
Published: (2022-11-01)

Evaluation of apoptosis indexes in currently used oral alpha-blockers in prostate: a pilot study
by: Mehmet Demir, et al.

Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
by: Antonio La Torre, et al.
Published: (2021-07-01)

Extracts of <i>Phyllostachys pubescens</i> Leaves Represses Human Steroid 5-Alpha Reductase Type 2 Promoter Activity in BHP-1 Cells and Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia in Rat Model
by: Kwang Hoon Song, et al.
Published: (2021-03-01)

Methylated CpG dinucleotides in the 5-α reductase 2 gene may explain finasteride resistance in benign prostatic enlargement patients
by: Zhe-Min Lin, et al.
Published: (2021-01-01)

Serenoa repens extracts: In vitro study of the 5α-reductase activity in a co-culture model for Benign Prostatic Hyperplasia
by: Daniela Buonocore, et al.
Published: (2018-09-01)

Effect of 5α-reductase inhibitors on the efficiency of thulium:yttrium-aluminium-garnet (RevoLix®) vaporesection for treating benign prostatic hyperplasia
by: Jae Seung Chung, et al.
Published: (2020-01-01)

Inhibitory Activities of Phenolic Compounds Isolated from Adina rubella Leaves Against 5α-Reductase Associated with Benign Prostatic Hypertrophy
by: Jun Yin, et al.
Published: (2016-07-01)

Preoperative treatment with 5α-reductase inhibitors and the risk of hemorrhagic events in patients undergoing transurethral resection of the prostate – A population-based cohort study
by: Ti-Yuan Yang, et al.
Published: (2018-03-01)

Sexual, physical, and overall adverse effects in patients treated with 5α-reductase inhibitors: a systematic review and meta-analysis
by: Jun-Jie Zhang, et al.
Published: (2022-01-01)

Hypothesis on Serenoa repens (Bartram) small extract inhibition of prostatic 5α-reductase through an in silico approach on 5β-reductase x-ray structure
by: Paolo Governa, et al.
Published: (2016-11-01)

DIFFERENCES IN THE EFFECTIVENESS OF SELECTIVE ALPHA BLOCKER THERAPY COMBINED WITH 5-ALPHA REDUCTASE INHIBITOR ON IPSS VALUE OF BPH LUTS PATIENTS
by: Septa Surya Wahyudi, et al.
Published: (2020-07-01)

<i>Trapa bispinosa</i> Roxb. Pericarp Extract Exerts 5α-Reductase Inhibitory Activity in Castrated Benign Prostatic Hyperplasia Model Mice
by: Takashi Fujita, et al.
Published: (2023-07-01)

Gamma Irradiated <i>Rhodiola sachalinensis</i> Extract Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia by Downregulating 5-Alpha Reductase and Restoring Testosterone in Rats
by: Qi Xin, et al.
Published: (2019-11-01)

Finasteride therapy in a dog with benign prostatic hyperplasia
by: Hyejin Kim
Published: (2022-09-01)

In Search of Differential Inhibitors of Aldose Reductase
by: Francesco Balestri, et al.
Published: (2022-03-01)

5-alpha-reductase deficiency: a case report
by: Diana Mettadewi Jong, et al.
Published: (2016-10-01)

The association of HIF-1α expression with clinicopathological significance in prostate cancer: a meta-analysis
by: Huang M, et al.
Published: (2018-08-01)

Use of 5-Alpha Reductase Inhibitors in Dermatology: A Narrative Review
by: Mariana Escamilla-Cruz, et al.
Published: (2023-07-01)

Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate Cancer
by: Jeri Kim, et al.
Published: (2016-05-01)

Advances of Ribonucleotide Reductase Inhibitors on Cancer
by: WANG An'ge, et al.
Published: (2019-08-01)

Identification of potential biomarkers and pivotal biological pathways for prostate cancer using bioinformatics analysis methods
by: Zihao He, et al.
Published: (2019-10-01)

Berberine Improves Benign Prostatic Hyperplasia via Suppression of 5 Alpha Reductase and Extracellular Signal-Regulated Kinase in Vivo and in Vitro
by: Dong-Hyun Youn, et al.
Published: (2018-07-01)

Changes of resistance indices after medication in benign prostatic hyperplasia: a prospective study
by: Dong Jin Park, et al.
Published: (2023-09-01)

Evidence of Pyrimethamine and Cycloguanil Analogues as Dual Inhibitors of <i>Trypanosoma brucei</i> Pteridine Reductase and Dihydrofolate Reductase
by: Giusy Tassone, et al.
Published: (2021-06-01)

Corrigendum: Berberine Improves Benign Prostatic Hyperplasia via Suppression of 5 Alpha Reductase and Extracellular Signal-Regulated Kinase in Vivo and in Vitro
by: Dong-Hyun Youn, et al.
Published: (2019-05-01)

Inhibitors of the Cancer Target Ribonucleotide Reductase, Past and Present
by: Sarah E. Huff, et al.
Published: (2022-06-01)

Biochemical and Histopathological evaluation of prostatic tissue under effect of Pterostilbene in benign prostatic hyperplasia rat model
by: Mohammed Ridha Jawad, et al.
Published: (2023-05-01)

A Combination of Natural Products, BenPros (Green Tea Extract, Soybean Extract and Camellia Japonica Oil), Ameliorates Benign Prostatic Hyperplasia
by: Subin Oh, et al.
Published: (2022-06-01)

Effects of Alginate Oligosaccharide on Testosterone-Induced Benign Prostatic Hyperplasia in Orchiectomized Rats
by: You-Jee Jang, et al.
Published: (2023-01-01)

Mini review on tricyclic compounds as an inhibitor of trypanothione reductase
by: Suresh Kumar, et al.
Published: (2014-01-01)